-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, QqeM8wFWID1PAJ6MDwbuoZXQZ3DqlHNYFYpoXgkqQloxvzzo3IkE5MZkONid2Hm+ DKj9dVqNFGj6EvCnNwzQkw== 0001404219-08-000020.txt : 20080613 0001404219-08-000020.hdr.sgml : 20080613 20080613164039 ACCESSION NUMBER: 0001404219-08-000020 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20080604 FILED AS OF DATE: 20080613 DATE AS OF CHANGE: 20080613 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GENENTECH INC CENTRAL INDEX KEY: 0000318771 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 942347624 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1 DNA WAY CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650-225-1000 MAIL ADDRESS: STREET 1: 1 DNA WAY STREET 2: . CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Tessier-Lavigne Marc CENTRAL INDEX KEY: 0001437435 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-09813 FILM NUMBER: 08898621 BUSINESS ADDRESS: BUSINESS PHONE: 650-225-1175 MAIL ADDRESS: STREET 1: 1 DNA WAY CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 3 1 edgardoc.xml PRIMARY DOCUMENT X0202 3 2008-06-04 0 0000318771 GENENTECH INC DNA 0001437435 Tessier-Lavigne Marc 1 DNA WAY SO SAN FRANCISCO CA 94080 0 1 0 0 EVP, RESEARCH DRUG DISCOVERY Common Stock 1159 D Non-Qualified Stock Option (right to buy) 53.23 2004-09-23 2014-09-23 Common Stock 24375 D Non-Qualified Stock Option (right to buy) 73.47 2008-10-18 2017-10-18 Common Stock 55000 D Non-Qualified Stock Option (right to buy) 79.17 2007-09-20 2016-09-20 Common Stock 72000 D Non-Qualified Stock Option (right to buy) 79.55 2008-09-20 2017-09-20 Common Stock 57000 D Non-Qualified Stock Option (right to buy) 85.83 2005-09-23 2015-09-23 Common Stock 75000 D This stock option vests over four years, with the first 25% of the shares vesting one year from the grant date and 75% of the shares vesting in equal monthly increments over the following three years. The option may be immediately exercisable with the consent of Genentech. This stock option vests over four years, with the first 25% of the shares vesting one year from the grant date and 75% of the shares vesting in equal monthly increments over the following three years. By: ADAM LAUTNER For: MARC T TESSIER-LAVIGNE 2008-06-13 -----END PRIVACY-ENHANCED MESSAGE-----